EP Patent

EP2558073A1 — Oral testosterone ester formulations and methods of treating testoterone deficiency comprising same

Assigned to Clarus Therapeutics Inc · Expires 2013-02-20 · 13y expired

What this patent protects

A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.

USPTO Abstract

A pharmaceutical formulation of testosterone undecanoate is provided. Methods of treating a testosterone deficiency or its symptoms with the inventive formulations are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP2558073A1
Jurisdiction
EP
Classification
—
Expires
2013-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Clarus Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.